Tag Archives: NYSE:DGX

Laboratory Corp. of America (NYSE:LH) Profit Tumbles on Higher Costs – LH, DGX, PMD, BRLI

Posted on April 20, 2013 by Thomas Vedder

Laboratory Corp. of America Holdings (NYSE:LH) announced fiscal Q1 earnings tumbled 8.9 percent as the company was hampered by higher outlays, though revenue and testing volume moved up.

The medical-testing services provider’s testing volume moved up 1.1 percent for the …

Posted in Healthcare, Latest Headlines | Tagged Bio-Reference Laboratories, BRLI, DGX, Laboratory, LH, NASDAQ:BRLI, NASDAQ:PMD, NYSE:DGX, NYSE:LH, PMD, Psychemedics, Quest Diagnostics | Comments Off

Healthcare Sector Quick Review: Abbott (NYSE:ABT), Quest Diagnostics (NYSE:DGX) – ABT, DGX, LH

Posted on April 18, 2013 by Thomas Vedder

Healthcare sector finished lower on Wednesday’s trading session and sector moved down -0.60%. If we consider key movers of this sector so XOMA Corp (NASDAQ:XOMA) and BioScrip Inc (NASDAQ:BIOS) were major percentage decliners while key percentage gainer was Alkermes Plc …

Posted in Healthcare, Latest Headlines | Tagged Abbott Laboratories, ABT, DGX, Laboratory, LH, NYSE:ABT, NYSE:DGX, NYSE:LH, Quest Diagnostics | Comments Off

Quest Diagnostics Inc.’s (NYSE:DGX) and Bank of New York Mellon Corp. (NYSE:BK) on Earnings Front

Posted on April 17, 2013 by Geoff Noir

Bank of New York Mellon Corp. (NYSE:BK) jumped to a first-quarter loss on a huge tax-associated charge, though the trust bank’s assets under management and care persisted to enhance.

Trust banks serves as custodians and servicers for corporations and Wall …

Posted in Latest Headlines | Tagged Bank of New York Mellon, BK, DGX, NYSE:BK, NYSE:DGX, Quest Diagnostics | Comments Off

Healthcare Sector Quick Roundup: Quest Diagnostics (NYSE:DGX), Synta Pharmaceuticals (NASDAQ:SNTA) – DGX, SNTA, PFE, CHDX, FLML, OREX

Posted on March 15, 2013 by Thomas Vedder

Thursday’s trading session data confirmed that healthcare sector finished positively with +0.34% change. Chindex International, Inc (NASDAQ:CHDX) and Flamel Technologies SA (ADR) (NASDAQ:FLML) were major percentage gainers in this sector while key percentage decliner was Orexigen Therapeutics, Inc (NASDAQ:OREX).

Quest …

Posted in Healthcare, Latest Headlines | Tagged CHDX, Chindex International, DGX, Flamel Technologies, FLML, NASDAQ:CHDX, NASDAQ:FLML, NASDAQ:OREX, NASDAQ:SNTA, NYSE:DGX, NYSE:PFE, OREX, Orexigen Therapeutics, PFE, Pfizer, Quest Diagnostics, SNTA, Synta Pharmaceuticals | Comments Off

Quest Diagnostics (NYSE:DGX) Chief Leaving Soon, Kirkland’s Inc.’s (NASDAQ:KIRK) on Earnings Chart

Posted on March 14, 2013 by Thomas Vedder

Kirkland’s Inc.’s (NASDAQ:KIRK) reported that its fiscal fourth-quarter earnings slid 6.1% as the discount home-decor retailer witnessed superior costs compensated enhanced revenue and lower margins.

For the quarter concluded Feb. 2, Kirkland’s (KIRK) declared a profit of $14.3 million, lower …

Posted in Latest Headlines | Tagged DGX, KIRK, Kirkland's, NASDAQ:KIRK, NYSE:DGX, Quest Diagnostics | Comments Off

Quest Diagnostics (NYSE:DGX) Plans to Shatter Costs; Lifts Dividend – BRLI, LH, PFE, BMY, MRX, DVAX, JNJ, MRK

Posted on November 16, 2012 by Geoff Noir

Quest Diagnostics Inc (NYSE:DGX) reported on Friday that the company is lifting its quarterly dividend by 76% to 30 cents per share.

The healthcare company announced that dividend will be payable on Jan 28 to shareholders of record on Jan …

Posted in Healthcare, Latest Headlines | Tagged Bio-Reference Laboratories, BMY, Bristol-Myers Squibb, BRLI, DGX, DVAX, Dynavax, JNJ, Johnson & Johnson, Laboratory, LH, Medicis Pharmaceutical, Merck, MRK, MRX, NASDAQ:BRLI, NASDAQ:DVAX, NYSE:BMY, NYSE:DGX, NYSE:JNJ, NYSE:LH, NYSE:MRK, NYSE:MRX, NYSE:PFE, PFE, Pfizer, Quest Diagnostics | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.